Pharmaceutical News and Articles

FDA Approves Vyloy (zolbetuximab-clzb) for the Treatment of Advanced Gastric and GEJ Cancer

Preventing, Treating Sports Injuries in Kids: A Guide

all the same qualities that helped them become good athletes. More informationThe American Academy of Pediatrics has more tips to prevent sports injuries in chi

Phase 2 study demonstrates the first successful clinical application of antifibrotic therapy for breast cancer

SAN DIEGO, Oct. 18, 2024. MeCo Diagnostics, a venture-backed startup dedicated to unlocking a new therapeutic modality for cancer, has announced a publication i

Want to Slowly Cut Down on Dietary Salt? Here's How

Did you know that sodium is the bad guy in salt, raising your risks for high blood pressure and other heart ills Luckily for Americans, the U.S. Food and Drug A

Standing More During the Day Does Not Cut Cardiovascular Risk

Standing more does not improve cardiovascular health and may increase the risk for circulatory issues, according to a study published online Oct. 16 in the Inte

Comorbid Diabetes Increases Risk for Lower Extremity Amputation With Kidney Disease

Patients with comorbid diabetes have an elevated risk for lower extremity amputation (LEA) at all stages of chronic kidney disease (CKD) compared with patients

Complete Vaccination Coverage Down in Kindergarteners for 2023-24 School Year

During the 2023-2024 school year, fewer U.S. kindergarteners had complete vaccinations than in prior years, according to a study published in the Oct. 17 issue

Current Tobacco Use Declining in U.S. Youth in 2024

Tobacco use among U.S. youth continued to decline in 2024, according to a study published in the Oct. 17 issue of the U.S. Centers for Disease Control and Preve

Smoking Tied to Increased Opioid Use

Increased opioid use is seen among adults who smoke cigarettes, according to a study recently published in the American Journal of Preventive Medicine. William

IDSA: Vaccination Less Likely With Increasing Social Vulnerability, Black Race

Vaccination for influenza, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), and respiratory syncytial virus (RSV) is less likely with an increasing